Buprenorphine

Overview

4.7 out of 5 (180 Reviews)

Credits

1.00

Post-Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

8 Jun 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Buprenorphine is a synthetic opioid developed in the late 1960s and is used to treat pain and opioid use disorder. This drug is a synthetic analog of thebaine—an alkaloid compound derived from the poppy flower. Buprenorphine is categorized as a Schedule III drug, which means it has a moderate-to-low potential for physical dependence or a high potential for psychological dependence. Buprenorphine is approved by the U.S. Food and Drug Administration (FDA) to treat acute and chronic pain and opioid dependence. This drug is used in agonist substitution treatment—a method for addressing addiction by substituting a more potent full agonist opioid, such as heroin, with a less potent opioid, such as buprenorphine or methadone. This activity reviews the FDA-approved indications, mechanism of action, administration, adverse event profile, toxicity, and drug interactions. This activity aims to empower healthcare professionals, working collaboratively within an interprofessional team, with essential knowledge and tools for optimal patient care during buprenorphine administration, enabling informed decision-making, dosage optimization, and minimizing adverse reactions to improve patient outcomes.


UAN: JA4008338-0000-23-867-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, nurse practitioners, dentists, and social workers.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate candidates for buprenorphine therapy based on a comprehensive assessment of opioid use disorders and patient history.

  • Implement evidence-based buprenorphine treatment regimens, considering dosing, administration routes, and patient-specific factors.

  • Select appropriate evidence-based treatment, adjunctive therapies, behavioral interventions, or counseling services to enhance the effectiveness of buprenorphine treatment.

  • Collaborate with pharmacists, nurses, and other interprofessional healthcare professionals to ensure comprehensive and coordinated patient care on buprenorphine therapy.

Pharmacy Activity Type:
General Pharmacy Topic


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-867-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Melanie D. on 9/25/2022

William E. on 8/17/2021

Daniel T. on 8/24/2021

Zinon P. on 8/31/2021

Kelli H. on 9/20/2021

Crista B. on 10/4/2021

Erik D. on 10/20/2021

Rachael S. on 10/24/2021

Mary C. on 11/10/2021

Justine W. on 1/4/2022

Frank F. on 12/29/2021

Thank you.

Douglas T. on 12/27/2021

Melanie G. on 1/21/2022

elizabeth d. on 2/10/2022

Jane O. on 3/7/2022

Linda P. on 3/6/2022

SANTHA A. on 3/15/2022

Jinelle S. on 3/29/2022

Lisa E. on 5/10/2022

Autumn M. on 6/30/2022

Spencer a. on 9/20/2022

Makenzie L. on 6/21/2021

Laurie C. on 10/9/2022

Lauralea T. on 6/20/2021

Steven F. on 11/16/2022

Jane O. on 4/12/2021

Ketan H. on 11/24/2022

Christine G. on 10/5/2022

Carrie H. on 10/3/2022

Ashley M. on 7/7/2022

Dr M. on 12/27/2022

Kim B. on 12/29/2022

Cameron G. on 6/25/2022

James P. on 6/23/2022

THEODORE T. on 1/8/2023

lesha s. on 6/13/2022

Jeffrey H. on 2/25/2023

Lauren I. on 5/28/2022

Megan G. on 5/18/2022

Brian K. on 5/16/2022

Kyle P. on 5/13/2022

Melissa D. on 4/27/2022

John G. on 3/28/2023

MARC M. on 4/17/2022

Masoud S. on 4/1/2023

Charlene N. on 4/15/2022

Christopher W. on 4/24/2023

david l. on 4/25/2023

Cynthia F. on 3/18/2022

Kathryn P. on 4/29/2023

Terri C. on 3/6/2022

Rodabeh M. on 2/20/2022

Wendy L. on 6/19/2023

Joseph F. on 6/14/2023

ANWAR S. on 11/17/2021

Kelsey G. on 8/29/2021

Caleigh S. on 7/3/2023

Theresa B. on 8/26/2021

Julie G. on 6/24/2021

Hannah B. on 7/24/2023

Richard K. on 8/31/2023

Jama G. on 9/12/2023

Kathleen P. on 10/31/2022

Hannah C. on 9/26/2023

Scott S. on 9/26/2023

Ashley W. on 9/28/2023

James S. on 7/11/2024

The content is good and easy to read, not overwhelming.

Albin C. on 10/1/2023

daniel h. on 10/5/2023

Donna C. on 12/1/2022

I think I understood the activity to say that a transdermal preparation of Buprenorphine is only available in Europe? Butrans is widely available in the US.

Maxwell H. on 10/14/2023

Teresa R. on 10/16/2023

Donna C. on 10/20/2023

Well done!

Jessica Z. on 12/12/2022

Eli N. on 9/23/2022

Stephen N. on 10/24/2023

Linda W. on 7/24/2022

Kery F. on 10/31/2023

Hannah J. on 11/10/2023

Kristen R. on 11/6/2023

Jihye J. on 1/3/2023

Tanya O. on 11/10/2023

Christina C. on 1/4/2023

Austin S. on 1/17/2023

Carol D. on 11/14/2023

Robert R. on 11/15/2023

steve k. on 11/16/2023

Jennifer A. on 2/4/2023

Attila G. on 2/10/2023

Joshua K. on 11/29/2023

Wayne S. on 2/11/2023

Jordan A. on 3/19/2023

Paula P. on 12/5/2023

Elizabeth S. on 12/8/2023

Michelle K. on 3/25/2023

David M. on 12/12/2023

guillaume c. on 4/1/2023

Brendalla G. on 4/23/2023

Susan h. on 4/28/2023

NICOLE R. on 5/12/2023

Rachel W. on 12/21/2023

Arkam R. on 12/24/2023

mariam g. on 6/5/2023

Anne D. on 11/18/2022

Keeon Z. on 11/25/2022

Tim d. on 12/27/2023

Stephen B. on 10/21/2023

Mary C. on 10/21/2023

Suzanne T. on 12/30/2023

Alvin O. on 12/31/2023

good addition to course listings

Otto S. on 10/29/2023

Michael M. on 11/7/2023

Kritsen Z. on 1/7/2024

Kayla S. on 1/10/2024

Denise W. on 11/11/2023

Lance H. on 11/13/2023

James N. on 11/23/2023

Denise M. on 11/27/2023

Kela L. on 1/23/2024

Carli H. on 1/25/2024

Caleb R. on 6/21/2023

Vu H. on 1/27/2024

Mandy S. on 1/30/2024

Dana R. on 6/24/2023

Carson T. on 7/15/2023

David T. on 2/11/2024

Gregory P. on 2/13/2024

Michelle T. on 7/20/2023

Ali D. on 9/25/2023

Mary Y. on 10/15/2023

Fadi S. on 3/17/2024

Karen J. on 3/17/2024

Mary S. on 3/20/2024

Cheryl M. on 3/20/2024

STEVEN B. on 3/20/2024

jesse b. on 3/21/2024

Look at Brixadi

Ginger S. on 3/21/2024

Scott S. on 12/29/2023

Karen C. on 3/27/2024

Kate J. on 4/1/2024

Helen S. on 4/7/2024

Corie B. on 4/10/2024

jeffrey m. on 4/10/2024

Thomas M. on 1/1/2024

Abigail M. on 1/6/2024

Kayven F. on 7/7/2024

Karen M. on 4/17/2024

Andres M. on 1/17/2024

Catherine B. on 12/1/2023

Madison E. on 5/4/2024

John G. on 5/28/2024

Kaitlyn C. on 6/3/2024

Ashleigh B. on 12/8/2023

Megan M. on 12/13/2023

Jerome G. on 12/17/2023

Emily V. on 6/17/2024

Thomas R. on 6/25/2024

thanks

Valentine C. on 7/4/2024

Lesly P. on 7/9/2024

Jennifer C. on 7/13/2024

Georgina S. on 12/19/2023

Michael N. on 12/26/2023

Stacey S. on 12/27/2023

Elisa H. on 12/27/2023

Jessica C. on 4/14/2024

Brandy S. on 4/12/2024

DYLAN A. on 4/17/2024

Cassandra J. on 4/18/2024

Stephen B. on 1/13/2024

Good review!

John B. on 4/19/2024

Gary B. on 1/26/2024

Michael O. on 5/4/2024

Tarahn A. on 6/7/2024

Brianna M. on 6/11/2024

Isabel R. on 2/1/2024

Bernard S. on 2/7/2024

Wassim E. on 2/26/2024

Christine D. on 3/22/2024

Christian P. on 7/18/2024

Nicole M. on 7/25/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user